Please login to the form below

Not currently logged in
Email:
Password:

Roche increases offer price for Genentech

Roche has increased its offer price for all outstanding publicly held shares of Genentech to $93 per share

Roche has increased its offer price for all outstanding publicly held shares of Genentech to $93 per share and extended the offer to 12:00 midnight, New York City time, on Friday, March 20, 2009. All other terms and conditions of the tender offer remain unchanged.

Franz B Humer, chairman of the Roche Group, said: "Based on conversations with Genentech shareholders, we believe there is a strong sentiment to bring this process to a conclusion. As a result, we are increasing our price to $93 per share."

The Offer to Purchase, Letter of Transmittal and other offering documents have been filed with the US Securities and Exchange Commission. As of the close of business on March 5, 2009, approximately 500,000 shares have been tendered pursuant to the offer.

9th March 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
BASTARD . LONDON

BASTARD . LONDON collaborates with you to amplify brand ideas into a visual brand language that resonates and engages with...

Latest intelligence

The gene therapy revolution
Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...
PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...

Infographics